Preparation and application of a class of organic UVB absorbing films based on TB-triphenylamine derivatives

By synthesizing TB-triphenylamine derivative-doped PVA films, the problem of selective UVB absorption in existing materials has been solved, achieving efficient UVB blocking and visible light transmission, making it suitable for human sun protection and sunscreen products.

CN117186456BActive Publication Date: 2026-11-17XUZHOU NORMAL UNIVERSITY
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202310914232.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-07-25
Publication Date
2026-11-17
Estimated Expiration
2043-07-25

AI Technical Summary

Technical Problem

Most existing ultraviolet absorbing materials absorb across the entire wavelength range, lacking materials that selectively absorb UVB. Furthermore, organic UV absorbers suffer from poor compatibility and migration/precipitation issues, which affect their practical applications.

Method used

By synthesizing PVA films based on TB-triphenylamine derivatives and doping them with first derivative 5 and second derivative 7, selective absorption of UVB is achieved, avoiding the problems of poor compatibility of inorganic materials and migration and precipitation of organic materials.

Benefits of technology

The prepared PVA-5 and PVA-7 films achieve high UVB blocking rate and high visible light transmittance at low content, and have low cost and a wide pH range, making them suitable for human sun protection products and glass, textiles and other fields.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117186456B_ABST
    Figure CN117186456B_ABST
Patent Text Reader

Abstract

This invention provides the preparation and application of organic UVB absorbing films based on TB-triphenylamine derivatives. Using 4-bromo-3-methoxyaniline, paraformaldehyde, 4-bromotriphenylamine, iodomethane, etc., as raw materials, a multi-step reaction was conducted to synthesize the following: The first derivative (5) and the second derivative (7) were respectively doped into polyvinyl alcohol (PVA) to obtain the corresponding organic UVB absorbing films PVA-5 and PVA-7. The prepared films have uniform distribution, high transparency, and excellent resistance to acid, alkali, solvents, and photodegradation. Photodynamic (PDT) experiments showed that the products have very low dark toxicity and phototoxicity to human liver immortalization (THLE-2) cells, and have the potential to be developed into UV light absorbing photocatalysts, human sunscreen products, and sunscreen products for glass and textiles.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of chemical synthesis, specifically involving Synthesis of base-triphenylamine derivatives; doping Preparation of PVA films based on triphenylamine derivatives and their applications in UVB light blocking and visible light transmission. Background Technology

[0002] Ultraviolet (UV) radiation is generally divided into three bands: UVA (320-400nm), UVB (320-280nm), and UVC (280-100nm). UVC has a shorter wavelength and is absorbed by the ozone layer in the atmosphere, so it cannot reach the ground.

[0003] UVA rays have a longer wavelength and can penetrate deep into the skin, leading to sunburn, sun damage, weakened immune system, and photoaging. However, UVA can act on 7-dehydrocholesterol in the sebaceous glands of the dermis, producing vitamin D3 through a series of reactions. As an important member of the vitamin D family, vitamin D3 promotes calcium and phosphorus absorption, bone metabolism, maintains blood calcium and phosphorus balance, promotes bone mineralization, and increases muscle strength and balance. It is an important drug for preventing and treating hypocalcemia, hypophosphatemia, rickets, osteomalacia, familial hypophosphatemia, hypoparathyroidism, tetany, postmenopausal osteoporosis, and osteoporosis in the elderly caused by vitamin D deficiency. Therefore, although the human body cannot be exposed to UVA radiation for extended periods, UVA is essential; without UVA exposure, the human body cannot synthesize the necessary vitamin D3.

[0004] UVB photons have high energy and can penetrate the superficial layers of the skin to reach the deepest layer of the epidermis—the basal layer. When chromophores in the skin (such as melanin) absorb UVB, they release energy, producing harmful reactive oxygen species (ROS) and reactive nitrogen species (RNS). ROS and RNS can accelerate skin aging, cause inflammation, sunburn, and even skin cancer. If high-energy UVB photons are directly absorbed by cellular DNA bases, they form cyclobutanepyrimidine dimers (CPD) and 6-4 photoproducts (6-4PPs). CPDs inhibit DNA replication and transcription, leading to cell death or mutation; while 6-4PPs alter DNA structure, causing sunburn and triggering melanin production, a major cause of melanoma in humans. Melanoma is a highly malignant tumor originating from melanocytes, and its incidence is increasing at an alarming rate of 4-5% annually. Even more alarming is the dramatic rise in melanoma cases among people aged 15-29, making it the third most common cancer, accounting for 11% of all new cancer cases each year. Moreover, the biological effects of UVB are 4,000-5,000 times stronger than those of UVA, and it is a major factor in inducing skin cancer, posing the greatest harm to the human body. Therefore, developing highly efficient protective materials that selectively absorb UVB is of great significance.

[0005] However, current UV-absorbing materials are all full-band absorbers, and there are no reports of UV-absorbing materials selectively absorbing UVB. Common UV absorbers are currently divided into inorganic and organic UV absorbers. Inorganic UV absorbers include ferric oxide, nano-silica, titanium dioxide, nano-zinc oxide, and cerium dioxide, which have advantages such as high specific surface energy and strong polarity. However, their compatibility with polymers is relatively poor, affecting the physical properties of polymers, such as mechanical properties and product color, thus impacting practical applications and limiting their application areas. Therefore, current research focuses on organic UV absorbers. Commonly used organic UV absorbers include benzotriazole, triazine, and benzophenone, most of which have long conjugated structures and multiple transition modes. However, traditional organic UV absorbers such as 2,4-dihydroxybenzophenone have relatively small molecular weights, and long-term use can lead to migration or precipitation. Therefore, it is necessary to develop new organic UV-absorbing materials that are simple, low-cost, and stable to reduce the harm of UV radiation to the human body.

[0006] TB and its derivatives have a unique V-shaped framework and a long conjugated structure. Under photon excitation, they exhibit multiple transition modes (π-π*, n-π*, and spatial transitions), and theoretically have a large molar absorption coefficient, making them an excellent basic framework for ultraviolet light absorption materials.

[0007] Triphenylamine (TPA) is a helical chromophore with a nitrogen center. This compound exhibits significant steric hindrance and hyperconjugated electronic effects, enhancing the stability of nitrogen radicals while also possessing high hole mobility. Introducing triphenylamine into TB can improve the overall electron-donating ability of the molecule, increasing the probability of electron transitions and thus enhancing its light absorption intensity and efficiency.

[0008] Given its structural and property advantages, a triphenylamine group was introduced into the TB framework to synthesize a TB-triphenylamine derivative 5. Based on this, the N atoms of the framework were converted into onium ions to improve its electron mobility, thus obtaining product 7. Its absorption performance for UVB was investigated in detail, which has broad prospects for the development and utilization of novel organic ultraviolet light absorbing materials. Summary of the Invention

[0009] Technical Problem: The purpose of this invention is to provide the preparation and application of a type of organic UVB absorbing membrane based on TB-triphenylamine derivatives. Using 4-bromo-3-methoxyaniline, paraformaldehyde, 4-bromotriphenylamine, iodomethane, etc., as raw materials, a multi-step reaction process is carried out to obtain... Base-triphenylamine derivatives were doped into PVA to prepare novel, highly efficient PVA- Base-triphenylamine organic ultraviolet absorbing films are used for UVB light blocking and visible light transmission.

[0010] Technical solution: The present invention provides a method for preparing an organic UVB absorbing film based on TB-triphenylamine derivatives, comprising the following steps:

[0011] Step 1: 2-Methoxy-4-bromoaniline 1 reacts with paraformaldehyde 2 to give the first intermediate 3, as shown in the following reaction formula:

[0012]

[0013] Step 2: The first intermediate 3 reacts with triphenylamine boric acid 4 to obtain the first derivative 5, as shown in the following reaction formula:

[0014]

[0015] Step 3: The first derivative 5 reacts with iodomethane 6 to give the second derivative 7, as shown in the following reaction formula:

[0016]

[0017] The first derivative 5 and the second derivative 7 were respectively doped into polyvinyl alcohol (PVA) to prepare the corresponding organic UVB absorbing films PVA-5 and PVA-7.

[0018] The polyvinyl alcohol (PVA) has a relative molecular mass MW = 3000 g / mol.

[0019] The first derivative 5 has three types of films, with masses of 0.1 wt%, 0.5 wt%, and 1.0 wt% in the PVA film, respectively; the second derivative 7 has three types of films, with masses of 0.1 wt%, 0.5 wt%, and 1.0 wt% in the PVA film, respectively.

[0020] The application of the organic UVB absorbing membrane based on TB-triphenylamine derivatives prepared by the method of the present invention, wherein the first derivative 5 and the second derivative 7 have dark toxicity and phototoxicity to human liver immortalized cells THLE-2.

[0021] Applications of the organic UVB absorbing film based on TB-triphenylamine derivatives prepared by the method of the present invention, and applications of the thin films PVA-5 and PVA-7 in shielding UVB.

[0022] Applications of the organic UVB absorbing film based on TB-triphenylamine derivatives prepared by the method of the present invention, and applications of the films PVA-5 and PVA-7 in blocking Rhodamine B fluorescence.

[0023] Applications of the organic UVB absorbing film based on TB-triphenylamine derivatives prepared by the method of the present invention, and the application of the PVA-5 and PVA-7 films in blocking the fluorescence of banknote anti-counterfeiting codes.

[0024] Applications of the organic UVB absorbing film based on TB-triphenylamine derivatives prepared by the method of the present invention, and applications of the thin films PVA-5 and PVA-7 in visible light transmission.

[0025] Beneficial effects:

[0026] 1. First synthesis Base-triphenylamine-based ultraviolet (UVB) absorbers are simple to synthesize and easy to process.

[0027] 2. The product has a wide pH range and can be used in human physiological environments.

[0028] 3. The product exhibits very low dark toxicity and phototoxicity to normal human liver immortalized cells (THLE-2).

[0029] 4. The prepared anti-UV film is a pure organic small molecule film, which can avoid the disadvantages of inorganic materials such as non-renewable, non-modifiable, and non-foldable. Moreover, it is easier to control the designability and adjustability of the molecular structure.

[0030] 5. The obtained UVB-resistant film has a high UVB light blocking rate. The blocking rates of PVA-5 and PVA-7 at lower contents (1.0 wt%) (92.3% and 96.2%, respectively) are higher than the literature values ​​(e.g., the UV blocking rate of 40 wt% carbon dot film is 90%).

[0031] 7. The obtained UVB-resistant film has high visible light transmittance (the visible light transmittance of PVA-5 and PVA-7 is 89.9% and 77.6%, respectively).

[0032] 8. Compared with commercially available UVB-resistant films, the prepared UV-resistant film has a lower cost.

[0033] 9. Current ultraviolet light absorbing materials absorb across the entire wavelength range. The PVA-5 and PVA-7 prepared in this invention absorb only UVB and not UVA, making them selective UVB absorbing materials. They have broad application prospects in ultraviolet light absorbing photocatalysts, sun protection products for human use, and sun protection products for glass, textiles, and other fields. Attached image description:

[0034] Figure 1 These are the (a) UV absorption and (b) fluorescence emission spectra of the first derivative 5 in different solvents in the examples; and the (c) UV absorption and (d) fluorescence emission spectra of the second derivative 7 in different solvents.

[0035] Figure 2 These are the solid-state fluorescence emission spectra of the first derivative 5 and the second derivative 7 in the embodiments;

[0036] Figure 3 The fluorescence emission spectra and line graphs of the first derivative 5(a) and 5(b) and the second derivative 7 in the embodiments at different pH values ​​are shown.

[0037] Figure 4 These are photographs of films (a) PVA-5 and (b) PVA-7 prepared in the examples with different contents (from left to right: 0.0wt%, 0.1wt%, 0.5wt%, 1.0wt%).

[0038] Figure 5 These are photographs of films (a) PVA-5 and (b) PVA-7 with different contents (from left to right: 0.1wt%, 0.5wt%, 1.0wt%) covered with the word "JSNU" prepared in the examples;

[0039] Figure 6 The transmission spectra of thin films (a) PVA-5 and (b) PVA-7 with different contents prepared in the examples are shown.

[0040] Figure 7 This is the transmission spectrum of a commercially available anti-UV film;

[0041] Figure 8 The fluorescence emission spectra and line graphs of the 1.0 wt% PVA-5(a) and PVA-7(b) films prepared in the examples at different pH values ​​are shown.

[0042] Figure 9 The fluorescence emission spectra and line graphs of the 1.0 wt% PVA-5(a) and PVA-7(b) films prepared in the examples in different solvents are shown.

[0043] Figure 10 The images show fluorescence images of Rhodamine B after the prepared films (a) blank, (b) PVA-5 (1.0 wt%) and (c) PVA-7 (1.0 wt%) were used to block a 310 nm UV lamp in the examples.

[0044] Figure 11 The survival rate of THLE-2 cells after incubation with different concentrations of compounds 5(a) and 7(b) in the examples under dark conditions or light for 48 hours is shown.

[0045] Figure 12 It is the first derivative 5 in the embodiment. 1 H NMR spectrum;

[0046] Figure 13 It is the first derivative 5 in the embodiment. 13 C NMR spectrum;

[0047] Figure 14 This is the HRMS spectrum of the first derivative 5 in the embodiment;

[0048] Figure 15 It is the second derivative 7 in the embodiment. 1 H NMR spectrum;

[0049] Figure 16 It is the second derivative 7 in the embodiment. 13 C NMR spectrum;

[0050] Figure 17 This is the HRMS spectrum of the second derivative 7 in the embodiment. Detailed implementation method:

[0051] The embodiments of the present invention are described in detail below. The embodiments described below are exemplary and are only used to explain the present invention, and should not be construed as limiting the present invention. Those skilled in the art will understand that various changes and modifications can be made to the present invention without departing from the spirit and scope thereof.

[0052] Example 1: Synthesis of first derivative 5 and second derivative 7

[0053] This invention provides the above-mentioned novel Methods for preparing base-triphenylamine derivatives 5 and 7 include:

[0054] In this embodiment, a class of materials was synthesized through multiple steps using 4-bromo-3-methoxyaniline, paraformaldehyde, 4-bromotriphenylamine, iodomethane, etc. Base-triphenylamine derivatives 5 and 7, including the following steps:

[0055] 1. Synthesis of the first intermediate 3

[0056] Weigh 11.16 g (60 mmol) of 4-bromo-3-methoxyaniline and 4.5 g (150 mmol) of paraformaldehyde into a 250 mL round-bottom flask and cool to -15 °C. Slowly add 120 mL of trifluoroacetic acid through a constant-pressure dropping funnel. After the addition is complete, move the reaction system to room temperature and react for seven days. Quench with ice water and adjust the pH to neutral with ammonia. A large amount of precipitate is produced. Filter, dry, weigh, and collect to obtain the first intermediate 3.

[0057]

[0058] 2. Synthesis of the first derivative 5

[0059] In a 100 mL round-bottom flask, 3 (2.0 mmol), 4 (2.2 mmol), tetrakis(triphenylphosphine)palladium (13.0 mmol), and potassium carbonate (0.2 mmol) were added sequentially. Under argon protection, 14 mL of toluene, 4 mL of ethanol, and 2 mL of distilled water were added, and the reaction was carried out at 90 °C for 12 h. After the reaction was complete (TLC monitoring), the mixture was extracted with ethyl acetate, the organic phase was dried over anhydrous sodium sulfate, and the crude product was obtained by rotary evaporation. The crude product was then purified by column chromatography (V... PE :V EA =2:1), yielding the first derivative 5 (yield 73%).

[0060]

[0061] The molecular formula of the first derivative 5 is: C 35 H 30 BrN3O2

[0062] The Chinese name is: 4-(8-bromo-3,9-dimethoxy-6H,12H-5,11-methyldibenzo[b,f][1,5]diazoazine-2-yl)-N,N-diphenylaniline

[0063] The English name is:

[0064] 4-(8-bromo-3,9-dimethoxy-6H,12H-5,11-methanodibenzo[b,f][1,5]diazocin-2-yl)-N,N-diphenylaniline

[0065] Appearance: White solid

[0066] Melting point: 117.2-117.6℃

[0067] 1H NMR spectrum: 1 H NMR (400MHz, CDCl3) δ7.34-7.29(m,2H),7.23(d,J=7.4Hz,4H),7.11(d,J=6.9Hz,5H),7.05(t,J=8.5Hz,2H),7.00(t,J=7.3Hz,2H),6.83(d,J=16.1Hz ,1H),6.69(t,J=12.0Hz,2H),4.64(dd,J=29.8,15.7Hz,2H),4.29(dt,J=2 0.9,10.6Hz,2H),4.16(dd,J=19.1,10.5Hz,2H),3.86(s,3H),3.80(s,3H).

[0068] Carbon NMR spectrum: 13 C NMR (100MHz, DMSO-d6)δ

[0069] Mass spectrometry: HRMS(ESI) m / z calcd for C 35 H 30 BrN3O2[M+H] + :604.1594; found,604.1546.

[0070] 3. Synthesis of the second derivative 7

[0071] Add 5 (1.0 mmol) to a 50 mL double-necked round-bottom flask, then add 10 mL of acetonitrile. Slowly add 6 (1.0 mL) dropwise with stirring at room temperature. After the addition is complete, reflux for 6 h. After the reaction is complete (tracked by TLC), allow the reaction system to cool naturally to room temperature, then slowly add diethyl ether. After a large amount of precipitate forms, filter the precipitate, wash the filter cake three times with diethyl ether, and dry to obtain the second derivative 7 (yield 81%). The specific reaction route is as follows:

[0072]

[0073] The molecular formula of the second derivative 7 is: C 36 H 33 BrIN3O2

[0074] The Chinese name is: 8-bromo-2-(4-(diphenylamino)phenyl)-3,9-dimethoxy-5-methyl-5,12-dihydro-6H-5,1-methyldibenzo[b,f][1,5]diazoazine-5-iodide

[0075] The English name is:

[0076] 8-bromo-2-(4-(diphenylamino)phenyl)-3,9-dimethoxy-5-methyl-5,12-dihydro-6H-5,11-methanodibenzo[b,f][1,5]diazocin-5-ium iodide

[0077] Appearance: White solid

[0078] Melting point: 220.3-220.8℃

[0079] 1H NMR spectrum: 1 H NMR (400MHz, DMSO-d6) δ7.74(t,J=11.9Hz,1H),7.41-7.33(m,4H),7.20(d,J=9.6Hz,1H),7.07(s,3H),7.02(t,J=11.0Hz,7H),6.97(d,J=7.0 Hz,2H),5.46(d,J=9.7Hz,1H),5.10(dd,J=55.3,13.8Hz,3H),4.82(d,J=16.7Hz,1H),4.52(d,J=16.1Hz,1H),4.03-3.83(m,3H),3.80(s,6H).

[0080] Carbon NMR spectrum: 13 C NMR (100MHz, CDCl3) δ168.16,168.12,137.87,136.91,136.64,136.25,135.10,134 .88,134.33,134.11,133.62,129.56,129.25,128.10,127.32,34.83,25.03,18.96.

[0081] Mass spectrometry: HRMS(ESI) m / z calcd for C 36 H 33 BrIN3O2[M+H] + :746.0874; found,746.0633.

[0082] Example 2: Solvation effect of first derivative 5 and second derivative 7

[0083] Derivative 5 and derivative 7 were respectively prepared into a concentration of 1×10⁻⁶ using 100 mL of N,N-dimethylformamide (DMF), dimethyl sulfoxide (DMSO), n-hexane, dichloromethane (CH₂Cl₂), toluene, tetrahydrofuran (THF), methanol, acetonitrile, and distilled water. -5 mol·L -1 The solution was analyzed, and its ultraviolet absorption and fluorescence emission spectra were measured. The optimal test solvent for subsequent experiments was selected by comprehensively considering factors such as solubility, absorbance, absorption wavelength, and luminescence properties. Figure 1 The optical properties of the first derivative 5 and the second derivative 7 were tested using THF, which has high absorbance in the ultraviolet region, as a solvent.

[0084] Example 3: Solid-state fluorescence spectra of first derivative 5 and second derivative 7

[0085] The first derivative 5 and the second derivative 7 were respectively laid flat and pressed into tablets, and their solid-state fluorescence emission spectra were measured. Figure 2 ).Depend on Figure 2 It can be seen that both the first derivative 5 and the second derivative 7 have stable solid-state fluorescence emission, indicating that they can be doped into the PVA film to determine its luminescence properties.

[0086] The spectral data of the first derivative 5 and the second derivative 7 are shown in Table 1:

[0087] Table 1 Spectral data of the products

[0088]

[0089] a Ultraviolet absorption wavelength in solution; b The molar extinction coefficient ε = A / bC, with units of L·mol⁻¹ -1 ·cm -1 ; c Fluorescence emission wavelength in solution; d Stokes displacement in solution; e Relative fluorescence quantum yield (reference: quinine sulfate); f Fluorescence intensity FB = ε*Φ, unit is L·mol -1 ·cm -1 ; g Solid-state excitation wavelength; h Solid-state fluorescence emission wavelength; i Solid-state Stokes displacement; j Lipid-water partition coefficient (ChemBioDraw Ultra simulation).

[0090] Example 4: pH range of each product of the present invention

[0091] pH range is one of the key factors for the successful application of a compound in biological systems. Therefore, we explored the pH range of the first derivative 5 and the second derivative 7.

[0092] The first derivative 5 and the second derivative 7 were prepared into concentrations of 1×10⁻⁶ using THF as a solvent. -4 mol·L -1 For each working solution, measure 1.0 mL of the working solution into a 10 mL volumetric flask, then add 1.0 mL of buffer solution with pH values ​​of 2.2-10 (citric acid / disodium hydrogen phosphate system for pH 2.2-8, and sodium bicarbonate / sodium carbonate system for pH 9-10), and dilute to volume with THF to a concentration of 1×10⁻⁶. -5 mol·L -1 Measure its fluorescence emission spectrum ( Figure 3 ).

[0093] Depend on Figure 3 It can be seen that when the solution pH is 7-10, the fluorescence emission spectra of the first derivative 5 and the second derivative 7 do not change significantly, indicating that they have a wide pH range and can be used in human physiological environments.

[0094] Example 5: Properties of the PVA films of the present invention

[0095] 1.0 g of polyvinyl alcohol (PVA, MW = 3000 g / mol) powder was dissolved in 20 mL of deionized water and stirred vigorously at 90 °C until the solution became clear. The solution was then cooled to room temperature. Derivative 5 and derivative 7 (0.1, 0.5, and 1.0 wt%) were added to the PVA solution, and the mixtures were stirred for 1 hour to obtain homogeneous solutions. The solutions were transferred to petri dishes using pipettes and dried at 90 °C for 1 day. Different concentrations of PVA-5 and PVA-7 (0.1, 0.5, and 1.0 wt%) were obtained. Figure 4 ).

[0096] Depend on Figure 5 It can be seen that the first derivative 5 and the second derivative 7 are evenly distributed in PVA. PVA-5 and PVA-7 are colorless and transparent under natural light. The increase in the content of the first derivative 5 and the second derivative 7 did not cause a change in the color of the film.

[0097] PVA films with different loadings all exhibit high transparency comparable to pure PVA films and can be used in subsequent experiments.

[0098] Example 6: Selection of PVA film loading in this invention

[0099] The transmittance of PVA-5 and PVA-7 was tested using a UV-Vis spectrophotometer. Figure 6 ).

[0100] Depend on Figure 6 It is known that PVA-5 and PVA-7 (0.1wt%, 0.5wt%, and 1.0wt%) have low UV transmittance in the 300-350nm range and excellent UV blocking ability. Furthermore, the UV transmittance decreases sharply with increasing content of the first derivative 5 and the second derivative 7. Calculations show that at a content of 1.0wt%, the UV blocking rates of PVA-5 and PVA-7 reach 92.3% and 96.2%, respectively. Compared with literature values ​​(40wt% carbon dot film has a UV blocking rate of 90%), PVA-5 and PVA-7 have lower contents and higher blocking rates.

[0101] The transmittance of PVA-5 and PVA-7 (0.1wt%, 0.5wt%, and 1.0wt%) in the visible light region of 500-800 nm was studied. Figure 6 As shown, with the increase of the content of the first derivative 5 and the second derivative 7, the transmittance of the film in the visible light range decreases slightly, but still maintains a transmittance of close to 70%. When the content of the first derivative 5 and the second derivative 7 is 1.0 wt%, their transmittance to visible light is 89.9% and 77.6%, respectively.

[0102] Therefore, the content of the first derivative 5 and the second derivative 7 at 1.0 wt% has the highest violet light blocking rate and visible light transmittance. Subsequent experiments selected 1.0 wt% as the optimal PVA film loading.

[0103] Depend on Figure 7 It is known that, compared with commercially available anti-UV films, the UV blocking rate of the anti-UV film synthesized in this patent is not much different. However, the film prepared in this patent is cheaper, and the light-absorbing compounds are all pure organic small molecules, which have many advantages and huge development prospects.

[0104] Example 7: Stability of various PVA films of the present invention

[0105] PVA-5 and PVA-7 were soaked for 12 hours at pH values ​​ranging from 2.2 to 14.0, then air-dried and subjected to acid and alkali resistance tests. Their fluorescence emission spectra were then measured. Figure 8 It can be seen that PVA-5 and PVA-7 can maintain their fluorescence intensity after being soaked for 12 hours under conditions of pH 2.2-14.0, indicating that PVA-5 and PVA-7 have high stability under both acidic and alkaline conditions.

[0106] PVA-5 and PVA-7 were soaked in different solvents for 24 hours, then dried, and solvent resistance tests were conducted to measure their fluorescence emission spectra. Figure 9 As shown, PVA-5 and PVA-7 can maintain their fluorescence intensity unchanged after being immersed in different solvents for 24 hours, indicating that PVA-5 and PVA-7 have good solvent resistance.

[0107] Example 8: Ultraviolet shielding capability of various PVA films of the present invention

[0108] Rhodamine B emits bright orange fluorescence under ultraviolet light. PVA-5 and PVA-7 were placed between Rhodamine B, and their fluorescence was compared with that without film shielding to test the UV shielding capabilities of PVA-5 and PVA-7. Figure 10 After using PVA-5 and PVA-7 to block a 310nm ultraviolet lamp, the fluorescence of Rhodamine B darkened, indicating that both PVA-5 and PVA-7 have UV shielding capabilities against 310nm ultraviolet light.

[0109] The security features on banknotes fluoresce under ultraviolet light. To visually demonstrate the UV protection capabilities of PVA-5 and PVA-7, a PVA film was placed between the banknote and the light source. The fluorescence brightness was compared to that when the light source was blocked by pure PVA film. Images were taken to test the UV shielding capabilities of PVA-5 and PVA-7. When the light source was blocked by pure PVA film, the security features on the banknote displayed a strong yellow light. When PVA-5 and PVA-7 were placed between the banknote and the light source respectively, the yellow fluorescence of the security features significantly decreased, indicating that both PVA-5 and PVA-7 have the ability to shield against 310nm light.

[0110] Example 9: Dark toxicity and phototoxicity of first derivative 5 and second derivative 7

[0111] The dark toxicity and phototoxicity of the compound on human liver immortalized cells (THLE-2) were detected by the MTT assay. After the test samples were prepared, THLE-2 cells were seeded into 96-well plates, and different concentrations of the compound were added. After incubation for 48 hours, the cells were irradiated with a photodynamic therapy device with a light source of 452 nm. The control group was not irradiated. Figure 11 As shown in Table 2, THLE-2 cells treated with the first derivative 5 and the second derivative 7 exhibited high survival rates under both dark and light conditions, indicating that the first derivative 5 and the second derivative 7 have negligible phototoxicity and dark toxicity, suggesting that they can be used as sunscreens in subsequent mouse experiments.

[0112] Table 2. Half-maximal inhibitory rates (IC50) of products 5 and 7 on THLE-2 cells. 50 )

[0113]

Claims

1. A method for preparing an organic UVB absorbing film based on TB-triphenylamine derivatives, characterized in that, The method includes the following steps: Step 1: 2-Methoxy-4-bromoaniline (1) reacts with paraformaldehyde (2) to obtain the first intermediate (3), as shown in the following reaction formula: Step 2: The first intermediate (3) reacts with triphenylamine boric acid (4) to obtain the first derivative (5), as shown in the following reaction formula: Step 3: The first derivative (5) reacts with iodomethane (6) to obtain the second derivative (7), as shown in the following reaction formula: The first derivative (5) and the second derivative (7) were respectively doped into polyvinyl alcohol (PVA) to prepare the corresponding organic UVB absorbing films PVA-5 and PVA-7.

2. The method for preparing the organic UVB absorbing membrane based on TB-triphenylamine derivatives according to claim 1, characterized in that, The polyvinyl alcohol (PVA) has a relative molecular mass MW = 3000 g / mol.

3. The method for preparing the organic UVB absorbing membrane based on TB-triphenylamine derivatives according to claim 1, characterized in that, The first derivative (5) has three types of films, with masses of 0.1 wt%, 0.5 wt%, and 1.0 wt% in the PVA film, respectively; the second derivative (7) has three types of films, with masses of 0.1 wt%, 0.5 wt%, and 1.0 wt% in the PVA film, respectively.

4. An application of an organic UVB absorbing membrane based on a TB-triphenylamine derivative prepared by the method of claim 1, characterized in that, The application of the aforementioned PVA-5 and PVA-7 films in shielding UVB.

5. An application of an organic UVB absorbing membrane based on a TB-triphenylamine derivative prepared by the method of claim 1, characterized in that, The application of the aforementioned thin films PVA-5 and PVA-7 in blocking Rhodamine B fluorescence.

6. An application of an organic UVB absorbing membrane based on a TB-triphenylamine derivative prepared by the method of claim 1, characterized in that, The application of the aforementioned PVA-5 and PVA-7 films in terms of visible light transmission.

Citation Information

Patent Citations

  • 4-(2-thienyl)triphenylamine and derivatives thereof, and preparation method and application of 4-(2-thienyl)triphenylamine and derivatives thereof

    CN109666018A

  • Tr*ger's base-Schiff base derivatives and production method and application thereof

    CN110627798A